Award details

Translational research in gene delivery/gene therapy and pharmacogenomics

ReferenceREI18501
Principal Investigator / Supervisor Professor Leonard Seymour
Co-Investigators /
Co-Supervisors
Professor David Kerr, Dr Robert Walton
Institution University of Oxford
DepartmentOncology
Funding typeResearch
Value (£) 26,508
StatusCompleted
TypeResearch Grant
Start date 01/04/2003
End date 31/01/2004
Duration10 months

Abstract

The purchase of an ABI PRISM Sequence Detector (Quantitative PCR Machine) will supplement analytical equipment available within the newly-commissioned Department of Clinical Pharmacology, and will be heavily used in a range of science-led basic and translational research projects in fields closely related to BBSRCs priority interests. The equipment will initially be used in two main fields: (i) Measurement of genomes of vectors for gene delivery/therapy. This will enable determination of - distribution kenetics, specific transduction activity and quantification of virus replication; (ii) Detection of single nucleotide polymorphisms in target genes associated with specific responses to treatment. This is a growing field where applications will proliferate. At present we plan three types of study: quantitate levels of allele-specific mRNA, seek to correlate responses to anticancer drugs, perform extensive pharmacogenetic typing in studies developing cyclo-oxygenase 2 inhibitors. The Q- PCR machine will also find other applications, although all will be within BBSRCs field of priority of Exploiting Genomics. The fields of gene delivery/gene therapy and pharmacogenomics reflect key areas of progress in this discipline, and will form the backbone of research in this new department.

Summary

unavailable
Committee Closed Committee - Engineering & Biological Systems (EBS)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative Research Equipment Initiative 2002 (REI) [2002]
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file